HOME > TOP STORIES

TOP STORIES

ORGANIZATION Generic Industry Pondering Specific Proposal to Address Unreasonable Price Rises

October 2, 2019
REGULATORY New Detailing Guidelines Go into Full Effect on October 1, Making Supervisory Systems Mandatory

October 1, 2019
BUSINESS AZ to Focus on Asthma-COPD Overlap in Marketing Triple-Combo Therapy Breztri, Will Help GPs Make Diagnosis

September 30, 2019
BUSINESS Amid Slow Uptake, Sysmex Pitching Its Genomic Profiling via Close Communications with Hospitals, Govt: Exec

September 27, 2019
REGULATORY Chuikyo Supports Earlier Price Cuts for Certain Off-Patent Brand-Name Drugs

September 26, 2019
ORGANIZATION EFPIA Japan Stresses Safety First and Need for Doctors’ Support on Delisting of OTC-Like Drugs, Notes Good Examples Overseas

September 25, 2019
REGULATORY Japan Approves Astellas’ HIF-PH Inhibitor, AbbVie’s Venclexta, Tecentriq’s Breast Cancer Use and More

September 24, 2019
BUSINESS SanBio’s Lead Cell Therapy Rides High with FDA’s RMAT Designation for Traumatic Brain Injury

September 20, 2019
BUSINESS Japan’s 1st Forteo Biosimilar Nears Market, Mochida Looks at Billion-Yen Sales

September 19, 2019
BUSINESS Luring Big Pharma with GPCR Work, Sosei Heptares Treads Its Own Path to Pursue Small Molecule Targets

September 18, 2019
BUSINESS Japan Still in Transition towards Comprehensive Genomic Profiling, Health Coverage Would Expand: Chugai Official

September 17, 2019
REGULATORY Show Us Concrete Proposals for Drug Pricing Reform: Kyokai Kenpo Director to Pharma

September 13, 2019
REGULATORY Both Payer, Doctor Members Want to Expand Comparator PMP Removal Rule, but Mixed on Timing: Chuikyo

September 12, 2019
INTERVIEW Pharma Industry Watered Down Original Proposals for Pricing Overhaul, Corrections Necessary: Kenporen Director

September 12, 2019
REGULATORY Katsunobu Kato Makes Comeback as Health Minister

September 11, 2019
BUSINESS Vital-Net Carving Out New Businesses in Regenerative Medicine, Robotics

September 11, 2019
REGULATORY MOF Budget Examiner Sounds Alarm on “Protected” Market, Prods Speedy Transformation

September 10, 2019
BUSINESS Daiichi Sankyo’s Big-Seller Hopeful DS-8201 Filed in Japan

September 10, 2019
BUSINESS To Counter Latuda Patent Cliff, Sumitomo Dainippon Poised to Buy 5 “Vants” Companies from Roivant

September 9, 2019
BUSINESS Labor Union Urges MSD Japan to Make Convincing Case on Job Cuts

September 6, 2019

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

G1 Rule to Hit Originator Biologics for First Time, Impact Seen for Up to 13 Brands

By Shinya Sato

Japan’s FY2026 drug pricing reform will, for the first time, apply the “G1” price cut rule for long-listed original biologics…

COLUMN

The Strategic MSL: Beyond Data Delivery, It’s About Impact

By Philip Carrigan

I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…